Grace Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -2,617 | -3,166 | -2,391 | -3,273 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,596 | -2,110 | -1,892 | -2,113 |
Cash | 19,394 | 23,005 | 18,545 | 26,991 |
Basic Shares | 9,399 | 9,399 | 9,399 | 9,399 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $196 |
Gross Profit | 0 | 120 | ||
Net Income | -12,853 | -42,429 | -9,819 | -19,678 |
Net Change In Cash | 0 | 0 | 0 | 196 |
Free Cash Flow | -12,355 | -15,930 | -17,234 | -14,388 |
Cash | 23,005 | 27,875 | 30,339 | 50,942 |
Basic Shares | 9,399 | 7,435 | 7,381 | 4,341 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.29 |
2024-06-30 | -$0.23 |
2024-03-31 | -$0.33 |
2023-12-31 | -$0.20 |
